Search Results - "Ge, Junbo"
-
1
Scientific research progress of COVID‐19/SARS‐CoV‐2 in the first five months
Published in Journal of cellular and molecular medicine (01-06-2020)“…A cluster of pneumonia (COVID‐19) cases have been found in Wuhan China in late December, 2019, and subsequently, a novel coronavirus with a positive stranded…”
Get full text
Journal Article -
2
Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases
Published in Frontiers in immunology (29-03-2019)“…Therapies aimed at minimizing adverse remodeling in cardiovascular diseases on a molecular and cellular basis are urgently needed. Exosomes are nanosized lipid…”
Get full text
Journal Article -
3
Cysteine Protease Cathepsins in Atherosclerotic Cardiovascular Diseases
Published in Journal of Atherosclerosis and Thrombosis (01-01-2018)“…Atherosclerotic cardiovascular disease (ASCVD) is an inflammatory disease characterized by extensive arterial wall matrix protein degradation. Cysteine…”
Get full text
Journal Article -
4
GSDMD-Mediated Cardiomyocyte Pyroptosis Promotes Myocardial I/R Injury
Published in Circulation research (23-07-2021)“…[Figure: see text]…”
Get full text
Journal Article -
5
Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease
Published in Nature reviews cardiology (01-02-2020)“…Lysine acetylation is a conserved, reversible, post-translational protein modification regulated by lysine acetyltransferases (KATs) and lysine deacetylases…”
Get full text
Journal Article -
6
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
Published in The New England journal of medicine (21-11-2019)“…In this randomized, placebo-controlled trial, investigators evaluated the effects of the sodium–glucose cotransporter 2 inhibitor dapagliflozin in patients…”
Get full text
Journal Article -
7
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Published in The New England journal of medicine (24-10-2019)“…Patients with heart failure with preserved ejection fraction were assigned to receive sacubitril–valsartan or valsartan. At a median of 35 months, there was no…”
Get full text
Journal Article -
8
Interleukin-35 Promotes Macrophage Survival and Improves Wound Healing After Myocardial Infarction in Mice
Published in Circulation research (26-04-2019)“…RATIONALE:Targeting inflammation has been shown to provide clinical benefit in the field of cardiovascular diseases. Although manipulating regulatory T-cell…”
Get full text
Journal Article -
9
The critical roles of m6A modification in metabolic abnormality and cardiovascular diseases
Published in Genes & diseases (01-11-2021)“…N6-methyladenosine (m6A) RNA methylation is an emerging area of epigenetics, which is a reversible and dynamic modification mediating by ‘writers’ (methylase,…”
Get full text
Journal Article -
10
Nanotechnology for cardiovascular diseases
Published in Innovation (New York, NY) (29-03-2022)“…Cardiovascular diseases have become the major killers in today's world, among which coronary artery diseases (CADs) make the greatest contributions to…”
Get full text
Journal Article -
11
Extracorporeal membrane oxygenation in the treatment of respiratory failure during COVID‑19
Published in Herz (01-06-2020)Get full text
Journal Article -
12
FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFM
Published in Cell death & disease (05-12-2022)“…Doxorubicin (DOX) is an effective anthracycline chemotherapeutic anticancer drug with its life-threatening cardiotoxicity severely limiting its clinical…”
Get full text
Journal Article -
13
Ticagrelor in Patients with Stable Coronary Disease and Diabetes
Published in The New England journal of medicine (03-10-2019)“…Patients with stable coronary artery disease and diabetes were randomly assigned to receive either ticagrelor plus aspirin or placebo plus aspirin. At 40…”
Get full text
Journal Article -
14
Initial resolution of the COVID-19 pandemic in China—can the virus return?
Published in Herz (01-06-2020)Get full text
Journal Article -
15
Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE−/−) mice
Published in Nanomedicine (01-01-2019)“…Although certain success has been achieved in atherosclerosis treatment, tremendous challenges remain in developing more efficient strategies to treat…”
Get full text
Journal Article -
16
CircUbe3a from M2 macrophage-derived small extracellular vesicles mediates myocardial fibrosis after acute myocardial infarction
Published in Theranostics (01-01-2021)“…This study aimed to explore the role of circular RNAs (circRNAs) in M2 macrophage (M2M)-derived small extracellular vesicles (SEVs) in myocardial fibrosis…”
Get full text
Journal Article -
17
SCN5A Variants: Association With Cardiac Disorders
Published in Frontiers in physiology (09-10-2018)“…The gene encodes the alpha subunit of the main cardiac sodium channel Na 1.5. This channel predominates inward sodium current (INa) and plays a critical role…”
Get full text
Journal Article -
18
Therapeutic silencing miR-146b-5p improves cardiac remodeling in a porcine model of myocardial infarction by modulating the wound reparative phenotype
Published in Protein & cell (01-03-2021)“…Fibrotic remodeling is an adverse consequence of immune response-driven phenotypic modulation of cardiac cells following myocardial infarction (MI)…”
Get full text
Journal Article -
19
Alpha-lipoic acid protects against pressure overload-induced heart failure via ALDH2-dependent Nrf1-FUNDC1 signaling
Published in Cell death & disease (30-07-2020)“…Alpha-lipoic acid (α-LA), a well-known antioxidant, was proved to active ALDH2 in nitrate tolerance and diabetic animal model. However, the therapeutic…”
Get full text
Journal Article -
20
Exosomal circHIPK3 Released from Hypoxia-Pretreated Cardiomyocytes Regulates Oxidative Damage in Cardiac Microvascular Endothelial Cells via the miR-29a/IGF-1 Pathway
Published in Oxidative medicine and cellular longevity (2019)“…Background/Aims. Circular RNAs (circRNAs) are a class of endogenous noncoding RNAs that regulate gene expression in eukaryotes. Recently, exosomes from…”
Get full text
Journal Article